Novaestiq Corp. — Form D/A

Novaestiq Corp. of SOUTHLAKE, TX, a company, filed a Form D amendment with the SEC on 2024-04-17. The offering totals $10.0M, of which $7.4M was reported sold. Industry: Other Health Care.

Offering

Filed: 2024-04-17
Form: D/A
Accession: 0001877943-24-000001
Industry: Other Health Care
Exemptions: 06b
Total offering: $10.0M
Amount sold: $7.4M
Remaining: $2.6M
Investors: 56
Date of first sale: 2021-07-30
Security types: debt
Revenue range: Decline to Disclose
SEC file number: 021-410241

Issuer

Name: Novaestiq Corp.
CIK: 0001877943
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2021
Address: 1560 EAST SOUTHLAKE BOULEVARD, SOUTHLAKE, TX, 76092
Phone: 817-781-0142

Officers, directors & promoters (6)

Name	Role	Location
Humberto David Antunes	Director	Southlake, TX
Miles David Harrison	Director	Southlake, TX
Humberto David Antunes	Executive Officer	Southlake, TX
Miles David Harrison	Executive Officer	Southlake, TX
Ethan David Rigel	Executive Officer	Southlake, TX
Andreas David Prinz	Director	Southlake, TX

Other filings by this issuer (4)

Filed	Form	Offering	Sold
2023-12-20	D/A	$7.5M	$3.8M
2021-10-05	D	$28K	$28K
2021-09-22	D/A	$7.5M	$300K
2021-08-17	D	$7.5M	$150K

More